Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 8.26
-0.602 %
$ 3.77 B
Market Cap
-9.49
P/E
AMRX - COST OF REVENUE
Cost of Revenue AMRX - Amneal Pharmaceuticals, Inc.
1.57 B
LAST VALUE
8.97%
2 YEAR CAGR
10.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR